Beyond the Scope: Cytopathology with Dr. Ritu Nayar

In this segment, Beyond the Scope, we speak to pathologists about their pursuits and interests in and outside of pathology.

On this episode, host Dr. Sara Jiang (@Sara_Jiang) speaks with Dr. Ritu Nayar (@NayarRitu). Dr. Nayar is the Vice Chair of Education and Faculty Development in the Department of Pathology at the Northwestern University Feinberg School of Medicine, where she is also the Director of Cytopathology and Professor of Pathology. Dr. Nayar is also the Past President of the American Society for Cytopathology, a past member of the Executive Council of the International Academy of Cytology and is currently a Trustee and President of the American Board of Pathology. She has published over 200 papers, including her work on The Bethesda System for Reporting Cervical Cytology. She has been recognized with lifetime achievement awards from College of American Pathologists, American Society of Cytopathology and the International Academy of Cytology.

 

Links to papers referenced in the episode:

1. Nayar, R. Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative. Cancer Cytopathology https://doi.org/10.1002/cncy.22733
   

    

Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States - PubMed (nih.gov).  

CA Cancer J Clin . 2023 Sep-Oct;73(5):458-460. doi: 10.3322/caac.21786. Epub 2023 Jun 22.

 

The time has come to implement primary human papillomavirus screening for cervical cancer in the United States - Franco - 2023 - Cancer - Wiley Online Library.

https://doi.org/10.1002/cncr.34899

 

Nayar, R. Precision Prevention: The 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J. Mol. Pathol. 2021, 2, 274-280. https://doi.org/10.3390/jmp2030023

Featured public domain music: US Army Blues, BugaBlue